Abstract
AbstractSentinel lymph node biopsy is fundamental in the staging of primary cutaneous melanoma (PCL), but reported lymphoscintigraphic patterns are very heterogeneous. In this systematic review, we evaluated the role of the popliteal station in below-knee PCL. A systematic search of literature through was conducted on the electronic databases PubMed, SCOPUS, and Web of Science (WOS) to identify eligible studies. A total of 22 studies (n=5673 patients) were included. During the analysis of the included articles, it was not possible to classify patients into the 3 Menes popliteal drainage pattern, obtained by lymphoscintigraphy. The analysis of lymphatic drainage in patients undergoing lymphoscintigraphy for melanoma of the lower extremities below the knee was reported in 5637 patients and the type of lymphatic popliteal drainage was reported only in 5.64% (320 patients). The rate of popliteal lymph nodes melanoma metastases was 1.49%: they were located exclusively at the popliteal level in 0.60%, at the popliteal and inguinal levels in 0.39%, at the popliteal and iliac level in 0.02%, and at the groin level in 0.48%. In conclusion, the most common lymphoscintigraphic pattern is represented by popliteal nodes in-transit or interval nodes, so metastases from below-knee melanomas commonly transit through popliteal nodes stations and arrive to inguinal nodes stations. The popliteal nodes are the primary station in about 5.64% of cases. Larger studies are needed to corroborate these findings.
Funder
Università degli Studi di Perugia
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Rapport F, Smith AL, Cust AE, Mann GJ, Watts CG, Gyorki DE, Henderson M, Hong AM, Kelly JW, Long GV, Mar VJ, Morton RL, Saw RPM, Scolyer RA, Spillane AJ, Thompson JF, Braithwaite J (2020) Identifying challenges to implementation of clinical practice guidelines for sentinel lymph node biopsy in patients with melanoma in Australia: protocol paper for a mixed methods study. BMJ Open. 10(2):e032636
2. Ferrara G, Partenzi A, Filosa A (2018) Sentinel node biopsy in melanoma: a short update. Dermatopathology. 5(1):21–25
3. Gershenwald JE, Scolyer RA (2018) Melanoma staging: American Joint Committee on Cancer (AJCC) 8th edition and beyond. Ann Surg Oncol. 25(8):2105–2110
4. Thomas JM (2008) Sentinel lymph node biopsy in malignant melanoma. BMJ. 336(7650):902–903
5. Associazione Italiana di Oncologia Medica (AIOM). Linee Guida Melanoma. 2019. Accessed October 5, 2020. https://www.aiom.it/wpcontent/uploads/2019/10/2019_LG_AIOM_Melanoma.pdf